7Baggers
 published on: 2025-11-15 03:08:51  newser.com Sat, 15 Nov 2025 09:08:51 GMT
 Published on: 2025-11-12 21:12:18  newser.com Thu, 13 Nov 2025 03:12:18 GMT
 capricor therapeutics shares slide ahead of critical data release  AD HOC NEWS Wed, 12 Nov 2025 11:42:04 GMT
 technical reactions to capr trends in macro strategies  news.stocktradersdaily.com Wed, 12 Nov 2025 00:30:02 GMT
 capricor: q3 earnings snapshot  ctinsider.com Tue, 11 Nov 2025 10:53:53 GMT
 Capricor Therapeutics (CAPR) Awaits Key Trial Results for Duchen  GuruFocus Tue, 11 Nov 2025 05:16:18 GMT
 Capricor Therapeutics Reports Q3 2025 Financial Results  TipRanks Tue, 11 Nov 2025 04:04:55 GMT
 capricor therapeutics q3 2025 earnings call transcript  MarketBeat Mon, 10 Nov 2025 22:41:15 GMT
 capricor: q3 earnings snapshot  News-Times Mon, 10 Nov 2025 22:28:19 GMT
 CAPRICOR THERAPEUTICS, INC. SEC 10-Q Report  TradingView Mon, 10 Nov 2025 22:23:00 GMT
 Capricor Therapeutics Banks On A Make-Or-Break 2026 Launch  Finimize Mon, 10 Nov 2025 22:02:08 GMT
 capricor (capr) nears critical milestone with phase 3 trial of d  GuruFocus Mon, 10 Nov 2025 21:33:16 GMT
 capricor therapeutics q3 net loss widens  MarketScreener Mon, 10 Nov 2025 21:18:16 GMT
 capricor therapeutics q3 2025 financial results  TradingView Mon, 10 Nov 2025 21:05:00 GMT
 published on: 2025-11-10 01:01:09  newser.com Mon, 10 Nov 2025 07:01:09 GMT
 published on: 2025-11-09 03:41:03  newser.com Sun, 09 Nov 2025 09:41:03 GMT
 Preview: Capricor Therapeutics's Earnings  Sahm Fri, 07 Nov 2025 08:00:00 GMT
 Capricor Therapeutics (CAPR) Prepares for Q3 Earnings Announceme  GuruFocus Fri, 07 Nov 2025 08:00:00 GMT
 published on: 2025-11-06 04:43:16  newser.com Thu, 06 Nov 2025 10:43:16 GMT
 capricor therapeutics banks on a make-or-break 2026 launch  Finimize Wed, 05 Nov 2025 08:00:00 GMT
 capricor therapeutics, inc. long-term shareholder  GlobeNewswire Tue, 04 Nov 2025 21:05:00 GMT

Capricor Therapeutics, Inc
(NASDAQ:CAPR) 

CAPR stock logo

Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has comp...

Founded: 2005
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends